David Weiner
Direttore/Membro del Consiglio presso BRIGHT MINDS BIOSCIENCES INC.
Patrimonio netto: - $ in data 30/04/2024
Profilo
David M.
Weiner is currently serving as the Co-Chairman at AxoSim, Inc. and as a Non-Executive Director at Bright Minds Biosciences, Inc. He is also the Chief Medical Officer at SwanBio Therapeutics, Inc. Previously, he held positions such as Chief Executive Officer at Amathus Therapeutics, Inc., Senior Medical Director at ACADIA Pharmaceuticals, Inc., Chief Medical Officer at aTyr Pharma, Inc., Faculty Member at the University of California San Diego and the University of Vermont, Vice President & Head-Early Clinical Development at EMD Serono, Inc., Chief Executive & Medical Officer at Proteostasis Therapeutics, Inc., Chief Medical Officer at Lumos Pharma Sub, Inc., and Chief Medical Officer at Chemomab Therapeutics Ltd.
Dr. Weiner completed his undergraduate degree at Brandeis University and obtained his doctorate from UB School of Medicine & Biomedical Sciences.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
05/02/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di David Weiner
Società | Posizione | Inizio |
---|---|---|
BRIGHT MINDS BIOSCIENCES INC. | Direttore/Membro del Consiglio | 17/02/2023 |
AxoSim, Inc.
AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Presidente | 28/02/2024 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di David Weiner
Società | Posizione | Fine |
---|---|---|
CHEMOMAB THERAPEUTICS LTD. | Direttore Tecnico/Scientifico/R&S | 14/11/2022 |
ATYR PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 19/07/2015 |
Amathus Therapeutics, Inc.
Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Amministratore Delegato | - |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Direttore Tecnico/Scientifico/R&S | - |
University of Vermont | Corporate Officer/Principal | - |
Formazione di David Weiner
Brandeis University | Undergraduate Degree |
UB School of Medicine & Biomedical Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
ACADIA PHARMACEUTICALS INC. | Health Technology |
ATYR PHARMA, INC. | Health Technology |
BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
CHEMOMAB THERAPEUTICS LTD. | Health Technology |
Aziende private | 6 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
Proteostasis Therapeutics, Inc.
Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
AxoSim, Inc.
AxoSim, Inc. Packaged SoftwareTechnology Services Axosim, Inc. operates as a biotechnology company that develops nerve-on-a-chip platform. The company was founded by Lowry Curley and Michael Moore and is headquartered in New Orleans, LA. | Technology Services |
Amathus Therapeutics, Inc.
Amathus Therapeutics, Inc. Investment ManagersFinance Amathus Therapeutics, Inc. engages in the development of small-molecule therapeutics for enhanced mitochondrial function for treatment lysosomal-storage disorders and neurodegenerative diseases. The company is headquartered in Cambridge, MA. | Finance |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
- Borsa valori
- Insiders
- David Weiner